Bio-Path Cash Flow - Quarterly (NASDAQ:BPTH)

Add to My Stocks
$1.01 $0.07 (6.48%) BPTH stock closing price Sep 19, 2018 (Closing)

For analyzing any company like Bio-Path from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Bio-Path profits one has to check the income statement and for Bio-Path debt one has to check the balance sheet. Bio-Path stock analysis shows negative net income cash flow of $-3.59M till 2018 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. Bio-Path has a negative cash and cash equivalents change of $-3.39M.

View and download details of Bio-Path cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-0.25M--0.2M--0.58M-0.16M-0.67M-0.44M-1.24M-0.65M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net---1.14M-1.25M-1.42M-1.34M-0.92M-0.86M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.02M-0.01M-0.53M-0.53M-0.53M-0.42M-0.33M-0.02M--
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--5.08M1.51M1.54M-9M9M--
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year5.97M9.37M8.85M13.85M3.55M----1.5M
Cash & Equivalents at Year End2.58M4.28M5.96M4.62M6.18M7.11M9.37M11.29M4.22M6.47M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Bio-Path stock comparison chart provides an easy way to compare the stock price with peers along with details of Bio-Path stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Bio-Path saw a negative change in Net Change in Cash and Cash Equivalents of $-3.39M till 2018 Q2. Apart from the Bio-Path stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-3.37M for BPTH.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.02M for BPTH till last quarter 2018 Q2 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for Bio-Path.

Key Financial Ratios For Bio-Path Cash Flow